Scott K. Howell

2.6k total citations
33 papers, 2.1k citations indexed

About

Scott K. Howell is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Scott K. Howell has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Scott K. Howell's work include Advanced Glycation End Products research (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Natural Antidiabetic Agents Studies (6 papers). Scott K. Howell is often cited by papers focused on Advanced Glycation End Products research (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Natural Antidiabetic Agents Studies (6 papers). Scott K. Howell collaborates with scholars based in United States, Australia and Canada. Scott K. Howell's co-authors include Paul J. Beisswenger, Benjamin S. Szwergold, Michael Mauer, Sundeep Lal, Roya Babaei‐Jadidi, Paul J. Thornalley, Robert G. Nelson, Nazeer Ahmed, Keith Drummond and Kenneth E. Smith and has published in prestigious journals such as Diabetes Care, Diabetes and Analytical Biochemistry.

In The Last Decade

Scott K. Howell

33 papers receiving 2.1k citations

Peers

Countries citing papers authored by Scott K. Howell

Since Specialization

Citations

This map shows the geographic impact of Scott K. Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott K. Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott K. Howell more than expected).

Fields of papers citing papers by Scott K. Howell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott K. Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott K. Howell. The network helps show where Scott K. Howell may publish in the future.

Co-authorship network of co-authors of Scott K. Howell

This figure shows the co-authorship network connecting the top 25 collaborators of Scott K. Howell. A scholar is included among the top collaborators of Scott K. Howell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott K. Howell. Scott K. Howell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection 2021 ·Open Forum Infectious Diseases ·(unknown), Katherine Rodríguez, Carlee Moser, Judith S. Currier, Theodoros Kelesidis, James H. Stein, Todd T. Brown, Scott K. Howell, Paul J. Beisswenger, Grace A. McComsey	3
2	Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study 2017 ·Diabetes Care ·Aramesh Saremi, Scott K. Howell, Dawn C. Schwenke, Gideon Bahn, Paul J. Beisswenger, Peter D. Reaven, (unknown)	72
3	Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes 2016 ·Diabetes ·Pierre‐Jean Saulnier, Kevin M. Wheelock, Scott K. Howell, E. Jennifer Weil, Stephanie K. Tanamas, William C. Knowler, Kevin V. Lemley, Michael Mauer, Berne Yee, Robert G. Nelson, Paul J. Beisswenger	70
4	Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation 2013 ·Amino Acids ·Paul J. Beisswenger, Scott K. Howell, Greg Russell, Michael E. Miller, Stephen S. Rich, Michael Mauer	31
5	Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products 2013 ·Diabetes Care ·Paul J. Beisswenger, Scott K. Howell, Gregory B. Russell, Michael E. Miller, Stephen S. Rich, Michael Mauer	116
6	Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with Type 2 diabetes uncontrolled by oral agents 2012 ·Journal of Diabetes and its Complications ·Olga V. Sakharova, (unknown), James Dziura, Geralyn Spollett, Scott K. Howell, Paul J. Beisswenger, Silvio E. Inzucchi	8
7	Two Fluorescent Wavelengths, 440 _ex /520 _em nm and 370 _ex /440 _em nm, Reflect Advanced Glycation and Oxidation End Products in Human Skin Without Diabetes 2011 ·Diabetes Technology & Therapeutics ·Paul J. Beisswenger, Scott K. Howell, Todd A. MacKenzie, Hugo Corstjens, Neelam Muizzuddin, Mary S. Matsui	43
8	Transglycation—A Potential New Mechanism for Deglycation of Schiff's Bases 2005 ·Annals of the New York Academy of Sciences ·Benjamin S. Szwergold, Scott K. Howell, Paul J. Beisswenger	23
9	Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes 2005 ·Diabetologia ·Nazeer Ahmed, Roya Babaei‐Jadidi, Scott K. Howell, Paul J. Beisswenger, Paul J. Thornalley	190
10	Methylglyoxal Can Modify GAPDH Activity and Structure 2005 ·Annals of the New York Academy of Sciences ·(unknown), Scott K. Howell, (unknown), Paul J. Beisswenger	86
11	Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes 2003 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Paul J. Beisswenger, Scott K. Howell, Kenneth E. Smith, Benjamin S. Szwergold	109
12	Nonenzymatic glycation/enzymatic deglycation: a novel hypothesis on the etiology of diabetic complications 2002 ·International Congress Series ·Benjamin S. Szwergold, Scott K. Howell, Paul J. Beisswenger	12
13	Human Fructosamine-3-Kinase 2001 ·Diabetes ·Benjamin S. Szwergold, Scott K. Howell, Paul J. Beisswenger	150
14	α-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia 2001 ·Diabetes Care ·Paul J. Beisswenger, Scott K. Howell, (unknown), (unknown), (unknown), Benjamin S. Szwergold	145
15	Mechanisms by which metformin reduces methylglyoxal levels: The role of a stable condensation product (triazepinone) 2000 ·Diabetes Research and Clinical Practice ·(unknown), Daniel Ruggiero-Lopez, Scott K. Howell, Benjamin S. Szwergold, Nicolas Wiernsperger	1
16	Metformin reduces systemic methylglyoxal levels in type 2 diabetes. 1999 ·Diabetes ·Paul J. Beisswenger, Scott K. Howell, (unknown), Sundeep Lal, Benjamin S. Szwergold	363
17	Improving the Specific Gravity Adjustment Method for Assessing Urinary Concentrations of Toxic Substances 1998 ·American Industrial Hygiene Association Journal ·(unknown), Scott K. Howell	27
18	Toxicity of paracetamol in cultured chick hepatocytes treated with methotrexate 1993 ·European Journal of Pharmacology Environmental Toxicology and Pharmacology ·(unknown), Jacqueline F. Sinclair, Scott K. Howell, (unknown), Peter R. Sinclair, Thomas H. Taylor	10
19	Daunorubicin-induced mammary tumors in the rat 1989 ·European Journal of Cancer and Clinical Oncology ·Scott K. Howell, L. Clifton Stephens, (unknown)	3
20	Daunorubicin-induced DNA lesions in isolated rat hepatocytes and mammary epithelial cells 1986 ·Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Scott K. Howell, Charles W. Haidle, Yeu‐Ming Wang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact